A share price of Pulmonx Corp [LUNG] is currently trading at $1.92, down -3.03%. An important factor to consider is whether the stock is rising or falling in short-term value. The LUNG shares have gain 20.00% over the last week, with a monthly amount glided 18.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulmonx Corp [NASDAQ: LUNG] stock has seen the most recent analyst activity on July 31, 2025, when Piper Sandler downgraded its rating to a Neutral but kept the price target unchanged to $2.50 for it. Previously, D. Boral Capital started tracking the stock with Buy rating on March 10, 2025, and set its price target to $17. On December 11, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $7.50 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $12 on June 04, 2024. Wells Fargo downgraded its rating to a Equal Weight and reduced its price target to $14 on February 23, 2024. Craig Hallum started tracking with a Buy rating for this stock on September 05, 2023, and assigned it a price target of $18. In a note dated February 27, 2023, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $10 to $15.
Pulmonx Corp experienced fluctuations in its stock price throughout the past year between $1.47 and $9.37. Currently, Wall Street analysts expect the stock to reach $3.25 within the next 12 months. Pulmonx Corp [NASDAQ: LUNG] shares were valued at $1.92 at the most recent close of the market. An investor can expect a potential return of 69.27% based on the average LUNG price forecast.
Analyzing the LUNG fundamentals
Trailing Twelve Months sales for Pulmonx Corp [NASDAQ:LUNG] were 90.55M which represents 14.80% growth. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.65%, Pretax Profit Margin comes in at -0.62%, and Net Profit Margin reading is -0.63%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.7 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.82.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7403 points at the first support level, and at 1.5605 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.1095, and for the 2nd resistance point, it is at 2.2989.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pulmonx Corp [NASDAQ:LUNG] is 5.34. On the other hand, the Quick Ratio is 4.62, and the Cash Ratio is 3.36. Considering the valuation of this stock, the price to sales ratio is 0.86, the price to book ratio is 1.13.
Transactions by insiders
Recent insider trading involved Williamson Steven S., PRESIDENT AND CEO, that happened on Sep 02 ’25 when 9648.0 shares were sold. Chief Financial Officer & PAO, Joshi Mehul completed a deal on Sep 02 ’25 to sell 7936.0 shares. Meanwhile, CHIEF COMMERCIAL OFFICER Rose Geoffrey Beran sold 6543.0 shares on Sep 02 ’25.
